Blood loss and transfusion requirements.

<div><p>Background</p><p>The outcome of patients undergoing major surgery treated with HES for hemodynamic optimization is unclear. This post-hoc analysis of a randomized clinical pilot trial investigated the impact of low-molecular balanced HES solutions on the coagulation s...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Alexander Eckers (19106390) (author)
مؤلفون آخرون:	Oliver Hunsicker (771610) (author), Claudia Spies (11807) (author), Felix Balzer (295591) (author), Kerstin Rubarth (11783812) (author), Christian von Heymann (20553) (author)
منشور في:	2024
الموضوعات:	Biochemistry Medicine Cell Biology Molecular Biology Neuroscience Biotechnology Developmental Biology Infectious Diseases Mathematical Sciences not elsewhere classified results may help hydroxyethyl starch compared first postoperative day viscoelastic coagulation laboratory directed hemodynamic algorithm crystalloid volume replacement low molecular 6 hemodynamic optimization coagulation system molecular hes xlink "> vivo effects transient effect transfusion requirements prospective double pod 1 mg dl mcf fibtem inform clinicians eudract 2008 ethics committee ethical approval data suggest crystalloids 408 crystalloid following clinical practice blood loss artificial colloids 88 ). 42 solution 20 )).
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

Blood loss and transfusion requirements.

مواد مشابهة